Navigation Links
USP releases first certified reference material
Date:9/24/2008

Rockville, Md., September 24, 2008 The U.S. Pharmacopeial (USP) Convention is pleased to announce the release of its first Certified Reference Material (CRM), Dextromethorphan Hydrobromide. USP recently became the first global pharmacopeia to receive International Organization for Standardization accreditation as producer of chemical CRMs.

This release provides pharmaceutical manufacturers with a new class of reference standard that ensures improved information for measurements of their products when meeting requirements set forth in the United States PharmacopeiaNational Formulary (USPNF). Each CRM comes with a Certificate of Analysis containing data on certified property value, uncertainty value and for the first time an expiration date (period of validity), all of which aim to produce a higher level of trueness and traceability in the measurement of product and ingredient specifications.

"The Dextromethorphan Hydrobromide CRM is a milestone for USP since it represents our first Certified Reference Material," said William Koch, Ph.D., USP's chief metrology officer. "By releasing the first pharmaceutical CRM from any pharmacopeia, USP is maintaining the high levels of scientific and metrological leadership that customers, regulators and practitioners around the world have come to expect from us."

Additional CRM features and applications include:

  • Metrologically based testing and statistical analysis;
  • Traceable to an accurate realization of the unit in which the property value is expressed;
  • Trueness and traceability of CRM measurement system helps with consistency and comparability of measurement data among labs and over time;
  • Data for calibration, validating processes, comparison and value assignment;
  • Values meet ISO 17025 documentation requirement for testing labs; and
  • CRM program meets the requirements of ISO 17025 and ISO Guide 34 for RMP.


'/>"/>

Contact: Sandra Kim
sek@usp.org
301-816-8241
US Pharmacopeia
Source:Eurekalert

Page: 1

Related medicine news :

1. Cleveland Clinic Press Releases Journal-Writing Book Write for Life: Healing Body, Mind, and Spirit Through Journal Writing by Sheppard B. Kominars, Ph.D.
2. Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators
3. JHA Releases 2007 U.S. Group Disability Mid-Year Market Survey Results
4. Verdict One Releases Directory of Board Certified Attorneys for Consumers
5. Academy releases emergency preparedness tools to enable millions more people to shelter in place
6. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
7. MITEM Releases Blue Iris eLaborate 8.6
8. Produce for Better Health Foundation Releases Statement on Study Saying Fruit & Vegetable Consumption Not Strongly Associated With Colon Cancer Risk
9. Patient Safety Authority Releases Advisory Focusing on Common Causes of Medication Errors
10. URAC Releases Issue Briefs Examining Stakeholders Views of Care Coordination Along the Healthcare Continuum
11. Cardiac Science Releases New Cardiac Rehabilitation System

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... Those extra helpings of gravy and dessert at the ...tline than previously thought. According to a new ...FASEB Journal ( http://www.fasebj.org ), a diet t...on genes that ultimately cause our bodies to store... a double-whammy as the already difficult task of ...
(Date:11/30/2009)...ike a pothole that worsens over time, so do knees,...NDAY, Nov. 30 (HealthDay News) -- If you,re a midd...ball court or hockey rink, take note: A new study ...st the risk of internal knee damage that could lea... injuries occurred in middle-age people who showed...
(Date:11/30/2009)..., , ENGLEWOOD, Colo., Nov. 30 /PRNewsw...nal presentation discussing what "culture of safet...day Symposium presentation, "Creating a Culture o...-system professionals discussing their experiences...culture of safety in pharmacy and the role of tech...
(Date:11/30/2009)..., , NEW YORK, Nov. 30 /PRNewswire/ -...earch report is available in its catalogue: ,, ...Opportunities ,, http://www.reportlinker.com/...s--Opportunities.html ,, Gene therapy promise...icine. Although no significant achievements for cu...
(Date:11/30/2009)...mproved screening, awareness may help delay progre... , MONDAY, Nov. 30 (HealthDay News) -- Medical...ates costs $185.5 billion a year, according to a n... billion while patients pay $36.1 billion in out-o...r female patient and $4,036 per male patient. Wome...
Breaking Medicine News(10 mins):Health News:Western diets turn on fat genes 2Health News:Lots of Exercise in Midlife May Lead to Osteoarthritis 2Health News:Lots of Exercise in Midlife May Lead to Osteoarthritis 3Health News:Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned 2Health News:Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned 3Health News:Reportlinker Adds Gene Therapy - Worldwide Market Challenges & Opportunities 2Health News:Reportlinker Adds Gene Therapy - Worldwide Market Challenges & Opportunities 3Health News:Reportlinker Adds Gene Therapy - Worldwide Market Challenges & Opportunities 4Health News:Reportlinker Adds Gene Therapy - Worldwide Market Challenges & Opportunities 5Health News:Osteoarthritis Costs U.S. Over $185 Billion a Year 2
...hance health , , INDIANAPOLIS, April 30 Heartlan...ch has developed the world,s first probiotic sweet...d to boost the immune system and promote digestive...strains of influenza. , , (Photo: http://www...
... against heart attack, too , , THURSDAY, A...ed a stroke can significantly reduce the odds of a...eir blood pressure and cholesterol, new research s...niversity and Medical School in Paris. "Among them...
...are frequently exposed to potentially damaging noi...there has been little reported on their risk for n...children under the age of 18 have some hearing los...s ear, nose and throat doctors, found that 4 in 5 ...
...articipants from the medical, scientific, and busi...gress on Anti-Aging Medicine,s Spring 2009 Session...ed The American Academy of Anti-Aging Medicine (A4...s and health practitioners in 105+ countries. With...
...ion (Nasdaq: KNSY ) is scheduled to present at t...are Conference at The Palace Hotel in New York, on..., Kensey Nash,s President & CEO, will deliver ...eracast.com/webcasts/bas/healthcare09/id78208658.c...
...eaches Children the Importance of Washing their Ha...rding a potential swine flu pandemic continue to s...ed in at least ten U.S. states and eight countries...w.newscom.com/cgi-bin/prnh/20070816/DCTH039LOGO ...
Other Medicine News:Health News:Ingredient in Probiotic Sweetener Boosts Immune System 2Health News:Managing Blood Pressure, Cholesterol Cuts Stroke Risk 2Health News:Children and teenagers at risk for noise-induced hearing loss, warn America's ENT doctors 2Health News:World Anti-Aging Congress 2009 Defies Global Economic Downturn, Demonstrating Strength of Anti-Aging Medical Movement 2Health News:World Anti-Aging Congress 2009 Defies Global Economic Downturn, Demonstrating Strength of Anti-Aging Medical Movement 3Health News:World Anti-Aging Congress 2009 Defies Global Economic Downturn, Demonstrating Strength of Anti-Aging Medical Movement 4Health News:World Anti-Aging Congress 2009 Defies Global Economic Downturn, Demonstrating Strength of Anti-Aging Medical Movement 5Health News:Hand Washing Can Help Fight Against the Swine Flu 2
(Date:11/30/2009)...0 Dr. Jocelyn Rapelyea, Associate ...rge Washington University Medical Center in Washin...fied with Breast-Specific Gamma Imaging (BSGI) can... needle biopsy as well, as for pre-operative local...gical Society of North America (RSNA). ,, BSGI ...
(Date:11/30/2009)...Italy, November 30 Health Robotics...development plans and product specifications,for a... Parenteral,Nutrition", a new key component of its... Las Vegas, ASHP (Booth # 114). , "I look... the,TPNstation,s blueprints and to find out if TP...
(Date:11/30/2009)...d CHICAGO, Nov. 30 Today at the 95... Radiological Society of North America (RSNA), Bay...nrollment of the first patient in an international... and safety of florbetaben (BAY 94-9172) PET imagi... brain, which are a pathological hallmark of Alzhe...
Breaking Medicine Technology:Breast-Specific Gamma Imaging Identifies Occult Lesions Using Multi-Modality Imaging for Biopsy 2Health Robotics to Unveil TPNstation(TM) at the American Society of Health-System Pharmacists on December 7th 2Health Robotics to Unveil TPNstation(TM) at the American Society of Health-System Pharmacists on December 7th 3Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 2Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 3Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 1Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 2Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 3Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 4Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 5Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 6Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 7Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 8Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 9Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 10Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 11Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 12Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 13Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 14Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 15Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 16Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 17Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 18AOBO Announces New Product Launch 13444 1AOBO Announces New Product Launch 13444 2AspireHR Completes Phase 1 SAP HR Initiative for Shire Pharmaceuticals 53928 1AspireHR Completes Phase 1 SAP HR Initiative for Shire Pharmaceuticals 53928 2AspireHR Completes Phase 1 SAP HR Initiative for Shire Pharmaceuticals 53928 3
...monstrates Clinical Activity, a Novel Mechanism,of...Inhibitors-, NEW HAVEN, Conn., April 16, 2007 /PRN...nc. today announced the presentation of,data valid...hillion,s NS4A antagonists, ACH-806, for the treat...2nd Annual Meeting of the,European Association for...
...(BUSINESS WIRE)--Apr 17, 2007 - GenVec, Inc.,(Nasd...sented at,the 97th annual meeting of the American ... support the use of adenovector systems,to deliver...ha)).,GenVec,s lead product candidate, TNFerade(TM...rrier, which contains the gene for,TNF(alpha), a p...
Other Medicine Technology:Achillion Presents Positive Data on Novel Mechanism for Treating,HCV at EASL Annual Meeting 2Achillion Presents Positive Data on Novel Mechanism for Treating,HCV at EASL Annual Meeting 3Achillion Presents Positive Data on Novel Mechanism for Treating,HCV at EASL Annual Meeting 4GenVec Announces New Research at AACR on Selectivity and Mechanism,of Action of TNF-Based Anti-Cancer Therapy 2GenVec Announces New Research at AACR on Selectivity and Mechanism,of Action of TNF-Based Anti-Cancer Therapy 3
...re highly accurate in detecting the presence of dr... by GC/MS testing. This assay provides a prelimina... (such as GC/MS) must be used in order to obtain a... applied to any drug of abuse test result, particu...
...cker version of TheraTears that is perfect for nig...tective film during the day. Because TheraTears Li...out a preservative so that unlike preserved gels, ...vative-induced irritation. And because of its pate...
...t Drops improve comfort on contact lens insertion ...s from your disinfecting system or from its bliste...place one or two drops of TheraTears on the lens r...go in much easier and much more comfortably. Then,...
...epared by coating the suture with a mixture of a c...yl lactylate. POLYSORB sutures are colored violet ...ed. POLYSORB™ sutures meet all requirements ...) and the European Pharmacopeia (EP) except for mi...
Medicine Products: